feed,title,long_url,short_url
Benzinga,"With FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And Reward",https://benzinga.com/general/biotech/24/05/39045373/with-fda-decision-date-approaching-analyst-downgrades-sarepta-on-balanced-risk-and-reward,https://da.gd/srlUCo
Benzinga,Nvidia's Record-Breaking Earnings Boost SOX And NASDAQ Indexes: What Investors Need To Know,https://benzinga.com/analyst-ratings/analyst-color/24/05/39045327/nvidias-record-breaking-earnings-boost-sox-and-nasdaq-indexes-what-investors-need-t,https://da.gd/ebqFL
